Transfusion Thresholds in Myocardial Inf...

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed. 

Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide. 

Dr. Centor discusses the diagnosis of primary aldosteronism with Dr. Jordana Cohen. 

ST-elevation myocardial infarction is a common and important condition. Myocardial infarction is a leading cause of morbidity and mortality so it is vital that we get the diagnosis and management of this condition right. To find out more about this problem and what we can do abou ... Show More

KYW Newsradio's Rasa Kaye and Deborah Heart and Lung Center's Cardiac Electrophysiologist Dr. Raffaele Corbisiero team up to discuss atrial fibrillation, the most common of arrhythmias and how it is diagnosed and treated. 

In this episode of Medicine Grand Rounders, Dr. Sanjeeb Bhattacharya - Director of the HFpEF clinic and Associate Program Director of the HVTI heart failure fellowship - goes over various clinical presentations of heart failure with preserved ejection fraction. Moderated by: Yasm ... Show More

Send us a textIn this episode, Dr. Matthew Fuda (Internal Medicine Resident) discusses the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary with Dr. Karen Konieczny (Cardiologist, Electrophysi ... Show More

Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the efficacy and safety of both thrombolytics in patients with large ischemic core.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398   

Amit joins Dr. Laura Young to take a pulse check with experts, and learn more about the structural management of obstructive HCM. They discuss the interventional perspective with interventional cardiologist Dr. Amar Krishnaswamy and surgical perspective from cardiothoracic surgeo ... Show More

In this 302nd episode I interview Dr. David Broussard, a cardiac anesthesiologist and Chair of Anesthesiology at Ochsner Medical Center in New Orleans. We discuss his approach to preparing for, and dealing with, adverse events and how to communicate about them to patients and fam ... Show More

Hypotension and shock are both recognized as complications post-cardiac surgery. Some patients may develop more severe shock refractory to fluids and catecholamines. This response is also known as today's podcast episode, topic: vasoplegia after cardiac surgery. For this discussi ... Show More

The SMART-CHOICE 3 trial demonstrated that clopidogrel monotherapy is more effective than aspirin monotherapy in reducing the risk of major adverse cardiac and cerebrovascular events in high-risk patients who completed standard dual antiplatelet therapy (DAPT) following percutane ... Show More

Dr. Lauren Kim discusses the use of normalized join-count in predicting emphysema progression with Dr. Sukhraj Virdee and Dr. Miranda Kirby.  CT Chest Imaging Using Normalized Join-Count:Predicting Emphysema Progression in the CanCOLD Study. Virdee et al. Radiology 2024; 312(1):e ... Show More